These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management. Barberà JA; Blanco I Drugs; 2009 Jun; 69(9):1153-71. PubMed ID: 19537834 [TBL] [Abstract][Full Text] [Related]
7. Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension. Wang L; Jin YZ; Zhao QH; Jiang R; Wu WH; Gong SG; He J; Liu JM; Jing ZC Int J Chron Obstruct Pulmon Dis; 2017; 12():3353-3360. PubMed ID: 29200842 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease. Jo YS; Park JH; Lee JK; Heo EY; Chung HS; Kim DK Int J Chron Obstruct Pulmon Dis; 2017; 12():2433-2443. PubMed ID: 28860738 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension associated with chronic obstructive pulmonary disease. Chhabra SK Indian J Chest Dis Allied Sci; 2010; 52(1):29-40. PubMed ID: 20364612 [TBL] [Abstract][Full Text] [Related]
10. Comparing cardiopulmonary exercise testing in severe COPD patients with and without pulmonary hypertension. Thirapatarapong W; Armstrong HF; Bartels MN Heart Lung Circ; 2014 Sep; 23(9):833-40. PubMed ID: 24793962 [TBL] [Abstract][Full Text] [Related]
11. Impact of chronic obstructive pulmonary disease on exercise ventilatory efficiency in heart failure. Apostolo A; Laveneziana P; Palange P; Agalbato C; Molle R; Popovic D; Bussotti M; Internullo M; Sciomer S; Bonini M; Alencar MC; Godinas L; Arbex F; Garcia G; Neder JA; Agostoni P Int J Cardiol; 2015; 189():134-40. PubMed ID: 25889444 [TBL] [Abstract][Full Text] [Related]
12. Right heart function in COPD. Macnee W Semin Respir Crit Care Med; 2010 Jun; 31(3):295-312. PubMed ID: 20496299 [TBL] [Abstract][Full Text] [Related]
13. Cardiopulmonary exercise test and PaO Skjørten I; Hilde JM; Melsom MN; Hisdal J; Hansteen V; Steine K; Humerfelt S Int J Chron Obstruct Pulmon Dis; 2018; 13():91-100. PubMed ID: 29339921 [TBL] [Abstract][Full Text] [Related]
15. Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data. Weiss TJ; Rosen Ramey D; Yang L; Liu X; Patel MJ; Rajpathak S; Bajwa EK; Lautsch D BMC Pulm Med; 2022 Oct; 22(1):383. PubMed ID: 36258171 [TBL] [Abstract][Full Text] [Related]
16. Ventilatory and cardiocirculatory exercise profiles in COPD: the role of pulmonary hypertension. Boerrigter BG; Bogaard HJ; Trip P; Groepenhoff H; Rietema H; Holverda S; Boonstra A; Postmus PE; Westerhof N; Vonk-Noordegraaf A Chest; 2012 Nov; 142(5):1166-1174. PubMed ID: 22556320 [TBL] [Abstract][Full Text] [Related]
17. Role of vasoactive intestinal peptide in chronic obstructive pulmonary disease with pulmonary hypertension. Lacedonia D; Valerio G; Palladino GP; Carpagnano GE; Correale M; Di Biase M; Foschino Barbaro MP Rejuvenation Res; 2014 Feb; 17(1):33-9. PubMed ID: 24228853 [TBL] [Abstract][Full Text] [Related]
18. The role of pulmonary pressure/cardiac index to identify pulmonary hemodynamic responders to acute oxygen breathing pulmonary hypertension COPD patients. Lupi-Herrera E; Sandoval J; Efren Santos L; Pulido T; Rosas-Peralta M Arch Cardiol Mex; 2011; 81(3):208-16. PubMed ID: 21975235 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and diagnosis of severe pulmonary hypertension in patients with chronic obstructive pulmonary disease. Mal H Curr Opin Pulm Med; 2007 Mar; 13(2):114-9. PubMed ID: 17255801 [TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension in COPD: a review and consideration of the role of arterial vasodilators. Burger CD COPD; 2009 Apr; 6(2):137-44. PubMed ID: 19378227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]